These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19432616)

  • 1. A survey of New Zealand RANZCOG Fellows on their use of the levonorgestrel intrauterine device in adolescents.
    Paterson H; Miller D; Devenish C
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):220-5. PubMed ID: 19432616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.
    Paterson H; Ashton J; Harrison-Woolrych M
    Contraception; 2009 Jun; 79(6):433-8. PubMed ID: 19442778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study investigating obstetricians' and gynaecologists' management of women requesting an intrauterine device.
    Black KI; Sakhaei T; Garland SM
    Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):184-8. PubMed ID: 20522078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
    Gemzell-Danielsson K; Inki P; Heikinheimo O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
    Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
    J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
    Radesic B; Sharma A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004.
    Tewari R; Kay VJ
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):28-37. PubMed ID: 16546814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
    Hohmann HL; Reeves MF; Chen BA; Perriera LK; Hayes JL; Creinin MD
    Contraception; 2012 Mar; 85(3):240-5. PubMed ID: 22067762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA; Veldhuis HM; Lagro-Janssen TL
    Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair loss with use of the levonorgestrel intrauterine device.
    Paterson H; Clifton J; Miller D; Ashton J; Harrison-Woolrych M
    Contraception; 2007 Oct; 76(4):306-9. PubMed ID: 17900442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
    Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
    Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
    Daud S; Ewies AA
    Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J; Aldrighi JM; de Lima GR
    Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.